TD Cowen has increased its price target for McKesson (NYSE:MCK) to $1,012 from $1,000, maintaining a Buy rating on the healthcare services company. This adjustment follows McKesson’s strong financial performance, including an adjusted operating income beat and raised guidance on adjusted EPS, which analysts believe will drive a positive market reaction despite the stock trading near its 52-week high.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
McKesson stock price target raised to $1,012 from $1,000 at TD Cowen
TD Cowen has increased its price target for McKesson (NYSE:MCK) to $1,012 from $1,000, maintaining a Buy rating on the healthcare services company. This adjustment follows McKesson’s strong financial performance, including an adjusted operating income beat and raised guidance on adjusted EPS, which analysts believe will drive a positive market reaction despite the stock trading near its 52-week high.